Selected research
Industry Research
Medical Sevofluran Industry Research Report 2026
Market perspective
The global Medical Sevofluran market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Medical Sevofluran is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Medical Sevofluran is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Medical Sevofluran is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Medical Sevofluran include Abbott Laboratories, Hengrui, Baxter, Abbvie, Shenzhen Mindray Bio-Medical Electronics, Scott Medical Products, Piramal, Mylan Seiyaku and Maruishi Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Medical Sevofluran market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medical Sevofluran Market by Company
Abbott Laboratories
Hengrui
Baxter
Abbvie
Shenzhen Mindray Bio-Medical Electronics
Scott Medical Products
Piramal
Mylan Seiyaku
Maruishi Pharmaceutical
Lunan
Jinan MingRui
Hikma
Collins Ltd
BOC Healthcare
Medical Sevofluran Segment by Type
Generic Drug
Original Drug
Medical Sevofluran Segment by Application
Children
Adults
Medical Sevofluran Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Sevofluran market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Sevofluran and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Sevofluran.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Medical Sevofluran manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Medical Sevofluran by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Medical Sevofluran in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Generic Drug
- Original Drug
Applications
- Children
- Adults
Companies covered
- Abbott Laboratories
- Hengrui
- Baxter
- Abbvie
- Shenzhen Mindray Bio-Medical Electronics
- Scott Medical Products
- Piramal
- Mylan Seiyaku
- Maruishi Pharmaceutical
- Lunan
- Jinan MingRui
- Hikma
- Collins Ltd
- BOC Healthcare
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Medical Sevofluran Market Size (2021-2032)
- 2.2.2 Global Medical Sevofluran Sales (2021-2032)
- 2.2.3 Global Medical Sevofluran Market Average Price (2021-2032)
- 2.3 Medical Sevofluran by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Generic Drug
- 2.3.3 Original Drug
- 2.4 Medical Sevofluran by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Children
- 2.4.3 Adults
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Medical Sevofluran Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Medical Sevofluran Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Medical Sevofluran Revenue of Manufacturers (2021-2026)
- 3.4 Global Medical Sevofluran Average Price by Manufacturers (2021-2026)
- 3.5 Global Medical Sevofluran Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Medical Sevofluran, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Medical Sevofluran, Product Type & Application
- 3.8 Global Manufacturers of Medical Sevofluran, Established Date
- 3.9 Global Medical Sevofluran Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott Laboratories
- 4.1.1 Abbott Laboratories Company Information
- 4.1.2 Abbott Laboratories Business Overview
- 4.1.3 Abbott Laboratories Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Laboratories Medical Sevofluran Product Portfolio
- 4.1.5 Abbott Laboratories Recent Developments
- 4.2 Hengrui
- 4.2.1 Hengrui Company Information
- 4.2.2 Hengrui Business Overview
- 4.2.3 Hengrui Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Hengrui Medical Sevofluran Product Portfolio
- 4.2.5 Hengrui Recent Developments
- 4.3 Baxter
- 4.3.1 Baxter Company Information
- 4.3.2 Baxter Business Overview
- 4.3.3 Baxter Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Baxter Medical Sevofluran Product Portfolio
- 4.3.5 Baxter Recent Developments
- 4.4 Abbvie
- 4.4.1 Abbvie Company Information
- 4.4.2 Abbvie Business Overview
- 4.4.3 Abbvie Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Abbvie Medical Sevofluran Product Portfolio
- 4.4.5 Abbvie Recent Developments
- 4.5 Shenzhen Mindray Bio-Medical Electronics
- 4.5.1 Shenzhen Mindray Bio-Medical Electronics Company Information
- 4.5.2 Shenzhen Mindray Bio-Medical Electronics Business Overview
- 4.5.3 Shenzhen Mindray Bio-Medical Electronics Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shenzhen Mindray Bio-Medical Electronics Medical Sevofluran Product Portfolio
- 4.5.5 Shenzhen Mindray Bio-Medical Electronics Recent Developments
- 4.6 Scott Medical Products
- 4.6.1 Scott Medical Products Company Information
- 4.6.2 Scott Medical Products Business Overview
- 4.6.3 Scott Medical Products Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Scott Medical Products Medical Sevofluran Product Portfolio
- 4.6.5 Scott Medical Products Recent Developments
- 4.7 Piramal
- 4.7.1 Piramal Company Information
- 4.7.2 Piramal Business Overview
- 4.7.3 Piramal Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Piramal Medical Sevofluran Product Portfolio
- 4.7.5 Piramal Recent Developments
- 4.8 Mylan Seiyaku
- 4.8.1 Mylan Seiyaku Company Information
- 4.8.2 Mylan Seiyaku Business Overview
- 4.8.3 Mylan Seiyaku Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Mylan Seiyaku Medical Sevofluran Product Portfolio
- 4.8.5 Mylan Seiyaku Recent Developments
- 4.9 Maruishi Pharmaceutical
- 4.9.1 Maruishi Pharmaceutical Company Information
- 4.9.2 Maruishi Pharmaceutical Business Overview
- 4.9.3 Maruishi Pharmaceutical Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Maruishi Pharmaceutical Medical Sevofluran Product Portfolio
- 4.9.5 Maruishi Pharmaceutical Recent Developments
- 4.10 Lunan
- 4.10.1 Lunan Company Information
- 4.10.2 Lunan Business Overview
- 4.10.3 Lunan Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Lunan Medical Sevofluran Product Portfolio
- 4.10.5 Lunan Recent Developments
- 4.11 Jinan MingRui
- 4.11.1 Jinan MingRui Company Information
- 4.11.2 Jinan MingRui Business Overview
- 4.11.3 Jinan MingRui Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Jinan MingRui Medical Sevofluran Product Portfolio
- 4.11.5 Jinan MingRui Recent Developments
- 4.12 Hikma
- 4.12.1 Hikma Company Information
- 4.12.2 Hikma Business Overview
- 4.12.3 Hikma Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hikma Medical Sevofluran Product Portfolio
- 4.12.5 Hikma Recent Developments
- 4.13 Collins Ltd
- 4.13.1 Collins Ltd Company Information
- 4.13.2 Collins Ltd Business Overview
- 4.13.3 Collins Ltd Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Collins Ltd Medical Sevofluran Product Portfolio
- 4.13.5 Collins Ltd Recent Developments
- 4.14 BOC Healthcare
- 4.14.1 BOC Healthcare Company Information
- 4.14.2 BOC Healthcare Business Overview
- 4.14.3 BOC Healthcare Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 BOC Healthcare Medical Sevofluran Product Portfolio
- 4.14.5 BOC Healthcare Recent Developments
5 Global Medical Sevofluran Market Scenario by Region
- 5.1 Global Medical Sevofluran Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Medical Sevofluran Sales by Region: 2021-2032
- 5.2.1 Global Medical Sevofluran Sales by Region: 2021-2026
- 5.2.2 Global Medical Sevofluran Sales by Region: 2027-2032
- 5.3 Global Medical Sevofluran Revenue by Region: 2021-2032
- 5.3.1 Global Medical Sevofluran Revenue by Region: 2021-2026
- 5.3.2 Global Medical Sevofluran Revenue by Region: 2027-2032
- 5.4 North America Medical Sevofluran Market Facts & Figures by Country
- 5.4.1 North America Medical Sevofluran Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Medical Sevofluran Sales by Country (2021-2032)
- 5.4.3 North America Medical Sevofluran Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Medical Sevofluran Market Facts & Figures by Country
- 5.5.1 Europe Medical Sevofluran Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Medical Sevofluran Sales by Country (2021-2032)
- 5.5.3 Europe Medical Sevofluran Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Medical Sevofluran Market Facts & Figures by Country
- 5.6.1 Asia Pacific Medical Sevofluran Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Medical Sevofluran Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Medical Sevofluran Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Medical Sevofluran Market Facts & Figures by Country
- 5.7.1 South America Medical Sevofluran Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Medical Sevofluran Sales by Country (2021-2032)
- 5.7.3 South America Medical Sevofluran Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Medical Sevofluran Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Medical Sevofluran Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Medical Sevofluran Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Medical Sevofluran Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Medical Sevofluran Sales by Type (2021-2032)
- 6.1.1 Global Medical Sevofluran Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Medical Sevofluran Sales Market Share by Type (2021-2032)
- 6.2 Global Medical Sevofluran Revenue by Type (2021-2032)
- 6.2.1 Global Medical Sevofluran Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Medical Sevofluran Revenue Market Share by Type (2021-2032)
- 6.3 Global Medical Sevofluran Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Medical Sevofluran Sales by Application (2021-2032)
- 7.1.1 Global Medical Sevofluran Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Medical Sevofluran Sales Market Share by Application (2021-2032)
- 7.2 Global Medical Sevofluran Revenue by Application (2021-2032)
- 7.2.1 Global Medical Sevofluran Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Medical Sevofluran Revenue Market Share by Application (2021-2032)
- 7.3 Global Medical Sevofluran Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Medical Sevofluran Value Chain Analysis
- 8.1.1 Medical Sevofluran Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Medical Sevofluran Production Mode & Process
- 8.2 Medical Sevofluran Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Medical Sevofluran Distributors
- 8.2.3 Medical Sevofluran Customers
9 Global Medical Sevofluran Analyzing Market Dynamics
- 9.1 Medical Sevofluran Industry Trends
- 9.2 Medical Sevofluran Industry Drivers
- 9.3 Medical Sevofluran Industry Opportunities and Challenges
- 9.4 Medical Sevofluran Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst